Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Unspecified Adult Solid Tumor, Protocol Specific 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma, Mantle-Cell 2 Lymphoma 2 Leukemia, Myeloid, Acute 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Congenital Abnormalities 2 Carcinoma, Non-Small-Cell Lung 2 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Thrombocythemia, Essential 1 Squamous Cell Carcinoma of Head and Neck 1 Solitary Fibrous Tumor, Pleural 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Mesothelioma, Malignant 1 Melanoma 1 Malignant Tumor of Ill-defined Site 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1

Interventions

Temozolomide 115 Bevacizumab 72 Radiotherapy 52 Radiation 23 Erlotinib Hydrochloride 13 Lomustine 12 pembrolizumab 11 Magnetic Resonance Spectroscopy 11 Vorinostat 10 Nivolumab 10 Surgical Procedures, Operative 9 Irinotecan 9 Sorafenib 8 Radiotherapy, Intensity-Modulated 8 Radiotherapy, Conformal 7 Immunoglobulin G 7 Everolimus 7 Drug Therapy 7 Disulfides 7 Radiosurgery 6 Granulocyte-Macrophage Colony-Stimulating Factor 6 Carmustine 6 antineoplaston AS 2-1 5 antineoplaston A10 5 Sirolimus 5 Cilengitide 5 veliparib 4 veledimex 4 temsirolimus 4 selinexor 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Glioblastoma × Pharmacogenomic Testing × Clear all

NCT03216499 2022-05-09

PT2385

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed

24 enrolled 11 charts

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡